22/05/2020 - 11:16

Invex raises $26m for clinical trials

22/05/2020 - 11:16

Bookmark

Save articles for future reference.

Invex Therapeutics has received a $5 million investment from Andrew Forrest’s Tattarang as part of a share placement, with the proceeds to go towards the company’s research into neurological diseases.

This article is only available to our paid subscribers.

To read this article and get full access to every insight Business News offers, subscribe today.

STANDING BY BUSINESS. TRUSTED BY BUSINESS.

Subscription Options